Management of Oligometastasis and Oligoprogression in Patients with Epidermal Growth Factor Receptor Mutation-Positive NSCLC in the Era of Third-Generation Tyrosine Kinase Inhibitors
Jeong Uk Lim
Topics & Concepts
MedicineEpidermal growth factor receptorGefitinibOncologyLung cancerTyrosine kinaseInternal medicineCancer researchMutationReceptorGeneticsBiologyGeneLung Cancer Treatments and MutationsLung Cancer Research StudiesLung Cancer Diagnosis and Treatment